Correlation Between Annexon and In8bio
Can any of the company-specific risk be diversified away by investing in both Annexon and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and In8bio Inc, you can compare the effects of market volatilities on Annexon and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and In8bio.
Diversification Opportunities for Annexon and In8bio
Very good diversification
The 3 months correlation between Annexon and In8bio is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Annexon i.e., Annexon and In8bio go up and down completely randomly.
Pair Corralation between Annexon and In8bio
Given the investment horizon of 90 days Annexon is expected to generate 0.3 times more return on investment than In8bio. However, Annexon is 3.38 times less risky than In8bio. It trades about -0.05 of its potential returns per unit of risk. In8bio Inc is currently generating about -0.02 per unit of risk. If you would invest 594.00 in Annexon on August 28, 2024 and sell it today you would lose (84.00) from holding Annexon or give up 14.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Annexon vs. In8bio Inc
Performance |
| Timeline |
| Annexon |
| In8bio Inc |
Annexon and In8bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annexon and In8bio
The main advantage of trading using opposite Annexon and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.| Annexon vs. Immix Biopharma | Annexon vs. Cns Pharmaceuticals | Annexon vs. Hepion Pharmaceuticals | Annexon vs. Day One Biopharmaceuticals |
| In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |